National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Nilotinib (Tasigna®) for the newly diagnosed Chronic Phase Philadelpha Chromosone positive CML.

Rapid Review

Commenced Completed Outcome
06/10/2010 22/10/2010 Full Pharmacoeconomic Evaluation Recommended.